Maximize Returns on Cryo-Cell International Inc. (CCEL) Investments Using Our Online Dividend Calculator.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Manhattan Bridge Capital Inc
Cross Timbers Royalty Trust
Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Enzo Biochem Inc. ($0.01 Par Value)
Nuveen New York Select Tax-Free Income Portfolio
VOC Energy Trust Units of Beneficial Interest
Ark Restaurants Corp.
Bluerock Homes Trust Inc.